Katie Ewer

Active 2001–2025

74
Papers
21,780
Citations
52
h-index
70
i10-index

Citations

Citations per year for Katie Ewer1974: 1 citations1991: 1 citations2001: 3 citations2002: 5 citations2003: 11 citations2004: 39 citations2005: 66 citations2006: 110 citations2007: 125 citations2008: 87 citations2009: 86 citations2010: 43 citations2011: 52 citations2012: 64 citations2013: 99 citations2014: 70 citations2015: 97 citations2016: 74 citations2017: 81 citations2018: 65 citations2019: 214 citations2020: 694 citations2021: 3,186 citations2022: 1,783 citations2023: 585 citations2024: 656 citations2025: 239 citations2026: 11 citations1975–1990: no citations, so these years are not shown1992–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,007 citing papers, 19.2% of this breakdownUnited Kingdom: 1,322 citing papers, 12.7% of this breakdownChina: 557 citing papers, 5.3% of this breakdownGermany: 471 citing papers, 4.5% of this breakdownItaly: 355 citing papers, 3.4% of this breakdownIndia: 351 citing papers, 3.4% of this breakdownCanada: 327 citing papers, 3.1% of this breakdownAustralia: 325 citing papers, 3.1% of this breakdownNetherlands: 315 citing papers, 3% of this breakdownFrance: 296 citing papers, 2.8% of this breakdownSwitzerland: 222 citing papers, 2.1% of this breakdownSouth Africa: 201 citing papers, 1.9% of this breakdown
0%19.2%Other 35.5%

Fields

  • Medicine81.7%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Immunology and Microbiology4.8%
  • Social Sciences3.2%
  • Mathematics1.8%
  • Agricultural and Biological Sciences0.5%
  • Other2.5%

Topics

  • SARS-CoV-2 and COVID-19 Research21%
  • COVID-19 Clinical Research Studies9.4%
  • Vaccine Coverage and Hesitancy5.8%
  • vaccines and immunoinformatics approaches4%
  • Immune responses and vaccinations2.7%
  • COVID-19 epidemiological studies2.7%
  • Other54.4%

Coauthors

All papers

Open in search
  1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick Lillie, Raburn M. Mallory, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F Mujadidi, Anusha Nana, Peter O’Reilly, Sherman D. Padayachee, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Alexandre Vargas Schwarzbold, Nisha Singh, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Richard Tarrant, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Marion Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Fatola Abayomi, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Yemi Adelaja, Gbadebo Adewetan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Thamires C. D. S. C Almeida and 665 more - The Lancet 2020 cited by 5,010

  2. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Almahamoudou Mahamar, Koualy Sanogo, Youssoufa Sidibé, Kalifa Diarra, Mamoudou Samassekou, Oumar Attaher, Amadou Tapily, Makonon Diallo, Oumar M Dicko, Mahamadou Kaya, Seydina O Maguiraga, Yaya Sankaré, Hama Yalcouye, Soumaïla Diarra, Sidi M. Niambele, Ismaila Théra, Issaka Sagara, Mala Sylla, Amagana Dolo, Nsajigwa Misidai, Sylvester Simando, Hania Msami, Omary Juma, Nicolaus Gutapaka, Rose Paul, Sarah Mswata, Ibrahim Sasamalo, Kasmir Johaness, Mwantumu Sultan, Annastazia Alexander, Isaac Kimaro, Kauye Lwanga, Mwajuma Mtungwe, Kassim Khamis, Lighton Rugarabam, Wilmina F. Kalinga, Mohammed Mohammed, Janeth Kamange, Jubilate Msangi, Batuli Mwaijande, Ivanny M. Mtaka, Matilda Mhapa, Tarsis Mlaganile, Thabit Mbaga, Rakiswendé Serge Yerbanga, Wendkouni Samtouma, Abdoul Aziz Sienou, Zachari Kabré, Wendinpui Jedida Muriel Ouedraogo, G. Armel Bienvenu Yarbanga, Issaka Zongo, Hamade Savadogo, Joseph Sanon, Judicael Compaore, Idrissa Kere, Ferdinand Lionel Yoni, Tewende Martine Sanre, Seydou Bienvenu Ouattara, Samuel Provstgaard-Morys, Danielle Woods, Robert W. Snow, Amek Nyaguara, Caroline Ngetsa, Lynette Isabella Ochola‐Oyier, Jennifer Musyoki, Marianne Munene, Noni Mumba, Uche J. Adetifa, Charles Muiruri, Jimmy Shangala Mwawaka and 19 more - The Lancet 2024 cited by 351

  3. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah C. Gilbert, Andrew J. Pollard, Jeremy Aboagye, K. F. Adams, Aabidah Ali, Elizabeth Allen, Jennifer L. Allison, Rachel Anslow, Edward H. Arbe-Barnes, Gavin Babbage, J. Kenneth Baillie, Megan Baker, Natalie Baker, Philip Baker, Ioana Baleanu, Juliana Ballaminut, Eleanor Barnes, Jordan R. Barrett, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Eleanor Berrie, Lisa Berry, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Tracey Bingham, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Thomas Bower, Amy Boyd, Tanja Brenner, Philip Bright, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Sharon Burge, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabera Puig, Anna Calvert, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Victoria Carter, Katrina Cathie, Ruth Challis, Sue Charlton, Irina Chelysheva, Jee-Sun Cho, Paola Cicconi, Liliana Cifuentes, Helen Clark, Elizabeth Clark, Tom Cole, Rachel Colin-Jones, Christopher P. Conlon, Aislinn Cook, Naomi S. Coombes, Rachel Cooper, Catherine A. Cosgrove, Karen Coy, Wendy E.M. Crocker, Christina J. Cunningham and 265 more - The Lancet 2020 cited by 2,614

  4. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Beveridge, Kevin R. Bewley, Phillip J. Brown, Emily Brunt, Karen R. Buttigieg, Susana Camara, Sue Charlton, Emily Chiplin, Paola Cicconi, Elizabeth Clutterbuck, Andrea M. Collins, Naomi S. Coombes, Sue Ann Costa Clemens, M. Davison, Tesfaye Demissie, Tanya Dinesh, Alexander D. Douglas, C.J. Duncan, Katherine R. W. Emary, Katie Ewer, Sally Felle, Daniela M. Ferreira, Adam Finn, Pedro M. Folegatti, Ross Fothergill, Sara Fraser, Harriet Garlant, Laura Gatcombe, Kerry Godwin, Anna L. Goodman, Christopher Green, Bassam Hallis, Thomas C. Hart, Paul T. Heath, Helen Hill, Adrian V. S. Hill, Daniel Jenkin, Mwila Kasanyinga, Simon Kerridge, Chanice Knight, Stephanie Leung, Vincenzo Libri, Patrick Lillie, Spyridoula Marinou, Joanna McGlashan, Alastair McGregor, Lorna McInroy, Angela M. Minassian, Yama F Mujadidi, Elizabeth J. Penn, Christos J. Petropoulos, Katrina M. Pollock, Pamela C. Proud, Samuel Provstgaard-Morys, Durga Rajapaska, Maheshi Ramasamy, Katherine Sanders, Imam H. Shaik, Nisha Singh, Andrew Smith, Matthew D. Snape, Rinn Song, Sonu Shrestha, Rebecca Sutherland, Emma C. Thomson, David P. J. Turner, Alice Webb-Bridges, Terri Wrin, Christopher J. Williams - Nature Medicine 2021 cited by 1,239

  5. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Fries, Jenny M. Reimer, Katie Ewer, Umesh Shaligram, Adrian V. S. Hill, Halidou Tinto - The Lancet 2021 cited by 458

  6. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Umesh Shaligram, Adrian V. S. Hill, Halidou Tinto - The Lancet Infectious Diseases 2022 cited by 288

  7. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Green, Christopher Green, Melanie Greenland, Catherine Hill, Helen Hill, Ian Hirsch, Alane Izu, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Natalie G. Marchevsky, Richard P. Marshall, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Anusha Nana, Sherman D. Padayachee, Daniel J. Phillips, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Adam Ritchie, Hannah Robinson, Alexandre Vargas Schwarzbold, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Thomas White, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Gbadebo Adewatan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Felipe B. Alvernaz, Fabio Santos Amorim, Claudia Sala Andrade, Foteini Andritsou, Rachel Anslow and 666 more - The Lancet 2021 cited by 1,208

  8. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - EBioMedicine 2022 cited by 146

  9. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Rinn Song, Matthew D. Snape, Richard Tarrant, Merryn Voysey, Marion Watson, Alexander D. Douglas, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Teresa Lambe, the Oxford COVID Vaccine Trial Group, Aabidah Ali, Elizabeth Allen, Megan Baker, Eleanor Barnes, Nicola Borthwick, Amy Boyd, Charlie Brown-O’Sullivan, Joshua Burgoyne, Nicholas Byard, Ingrid Cabrera Puig, Federica Cappuccini, Jee-Sun Cho, Paola Cicconi, Elizabeth Clark, Wendy E.M. Crocker, Mehreen S. Datoo, H. Dele Davies, Francesca R. Donnellan, Susanna Dunachie, Nick J. Edwards, Sean C. Elias, Julie Furze, Ciarán Gilbride, Giacomo Gorini, Gaurav Gupta, Stephanie A. Harris, Susanne H. Hodgson, Mimi M. Hou, Susan Jackson, Kathryn Jones, Reshma Kailath, Lloyd D. W. King, Colin W. Larkworthy, Yuanyuan Li, Amelia M. Lias, Aline Linder, Samuel Lipworth, Raquel Lopez Ramon, Meera Madhavan, Emma Marlow, Julia L. Marshall, Alexander J. Mentzer, Hazel Morrison, Nathifa Moya, Ekta Mukhopadhyay, Andrés Noé, Fay L. Nugent, Dimitra Pipini, David Pulido-Gomez, Fernando Ramos Lopez, Adam Ritchie, Indra Rudiansyah, Stephannie Salvador and 184 more - Nature Medicine 2020 cited by 643

  10. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bassam Hallis, Paul T. Heath, Jodie Hay, Helen Hill, Daniel Jenkin, Simon Kerridge, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Catherine Ludden, Natalie G. Marchevsky, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Daniel J. Phillips, Emma Plested, Katrina M. Pollock, Hannah Robinson, Darren Smith, Rinn Song, Matthew D. Snape, Rebecca Sutherland, Emma C. Thomson, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Christopher J. Williams, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Merryn Voysey, Maheshi Ramasamy, Andrew J. Pollard - The Lancet 2021 cited by 651

  11. Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2016 cited by 330

  12. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 66

  13. Viral vectors as vaccine platforms: from immunogenicity to impact

    Authors: , , , , , - Current Opinion in Immunology 2016 cited by 186

  14. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca Makinson, Jack Mellors, Angela M. Minassian, Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Christine S. Rollier, Rinn Song, Matthew D. Snape, Richard Tarrant, Stephen Taylor, Kelly Thomas, Merryn Voysey, Marion Watson, Daniel Wright, Alexander D. Douglas, Catherine Green, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, the Oxford COVID Vaccine Trial Group, Jeremy Aboagye, Jennifer Alderson, Aabidah Ali, Elizabeth Allen, Lauren Allen, Rachel Anslow, Carolina V. Arancibia-Cárcamo, Edward H. Arbe-Barnes, Megan Baker, Philip Baker, Natalie Baker, Ioana Baleanu, Eleanor Barnes, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Amy Boyd, Tanja Brenner, Philip N. Brown, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabrera Puig, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Jim Chadwick, Irina Chelysheva, Jee-Sun Cho, Liliana Cifuentes, Elizabeth Clark, Rachel Colin-Jones and 203 more - Nature Medicine 2020 cited by 340

  15. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rinn Song, Danielle Woods, Gavin Screaton, Sarah C. Gilbert, Merryn Voysey, Andrew J. Pollard, Teresa Lambe, Syed Adlou, Robert Aley, Aabidah Ali, Rachel Anslow, Megan Baker, Phillip Baker, Jordan R. Barrett, Louise Bates, Kirsten Beadon, Rebecca Beckley, Jonathan Bell, Duncan Bellamy, Amy Beveridge, Cameron Bissett, Luke Blackwell, Heather Bletchly, Amy Boyd, Alice Bridges-Webb, Charlie Brown, Nicholas Byard, Susana Camara, Liliana Cifuentes Gutierrez, Andrea M. Collins, Rachel Cooper, Wendy E.M. Crocker, Thomas C. Darton, H. Dele Davies, J Davies, Tesfaye Demissie, Claudio Di Maso, Tanya Dinesh, Francesca R. Donnellan, Alexander D. Douglas, Rachael Drake-Brockman, C.J. Duncan, Sean C. Elias, Katherine R. W. Emary, Mutjaba Farooq, Saul N. Faust, Sally Felle, Daniela M. Ferreira, Carla Ferreira Da Silva, Adam Finn, Karen Ford, Emma Francis, Julie Furze, Michelle Fuskova, Eva Galiza, Ana Gibertoni Cruz, Leila Godfrey, Anna L. Goodman, Catherine Green, Christopher Green, Nicola M. Greenwood, Daisy Harrison, Thomas C. Hart, Sophia Hawkins, Paul T. Heath, Helen Hill, Kushalinii Hillson, Bryn Horsington, Mimi M. Hou, Elizabeth Howe and 87 more - The Lancet 2021 cited by 258

  16. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanna Nguyen, Lucia Parolini, Claire Petersen, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Hannah Robinson, Nicola Robinson, Patpong Rongkard, Fiona Ryan, Sonia Serrano, Timothy Tipoe, Merryn Voysey, Anele Waters, Panagiota Zacharopoulou, Eleanor Barnes, Susanna Dunachie, Philip Goulder, Paul Klenerman, Gavin Screaton, Alan Winston, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Sarah Fidler, Julie Fox, Teresa Lambe, Marion Watson, Rinn Song, Paola Cicconi, Angela M. Minassian, Sagida Bibi, Simon Kerridge, Nisha Singh, Catherine Green, Alexander D. Douglas, Alison M. Lawrie, Elizabeth Clutterbuck - The Lancet HIV 2021 cited by 256

  17. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 236

  18. Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Microbe 2021 cited by 59

  19. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2013 cited by 293

  20. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2024 cited by 48

  21. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , François Roman, Iris De Ryck, Alfredo Nicosia, Nancy J. Sullivan, Daphne A. Stanley, Olivier Tshiani Mbaya, Julie E. Ledgerwood, Richard Schwartz, Loredana Siani, Stefano Colloca, Antonella Folgori, Stefania Di Marco, Riccardo Cortese, Edward Wright, Stephan Becker, Barney S. Graham, Richard A. Koup, Myron M. Levine, Ariane Volkmann, Paul Chaplin, Andrew J. Pollard, Simon J. Draper, W. Ripley Ballou, Alison M. Lawrie, Sarah C. Gilbert, Adrian V. S. Hill - New England Journal of Medicine 2015 cited by 356

  22. Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2012 cited by 303

  23. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adrian V. S. Hill - The Journal of Infectious Diseases 2016 cited by 96

  24. Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials

    Authors: , , , , , , - Vaccines 2018 cited by 85